Positive Multifocal PSMA PET/CT in a Patient With Prostate Cancer and Follicular Lymphoma.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 34319949.
- Also identified by DOI 10.1097/RLU.0000000000003828 and PMC identifier 10258658.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Prostate-specific membrane antigen (PSMA) PET/CT is a highly reliable nuclear tracer for diagnostic imaging of prostate cancer. However, PSMA is also expressed by some nonprostatic tissues such as benign tumors, inflammatory processes, and malignant neoplasms. This case presents a patient with prostate cancer and follicular lymphoma undergoing PSMA PET/CT. Remarkably, both tumor entities were clearly detected in the scan. Yet, the 2 malignancies demonstrated rather different ranges in terms of SUVmax uptake values and therefore still enabled precise and accurate discrimination of prostate cancer and follicular lymphoma.
Medical subject headings
- Lymphoma, Follicular
- Prostatic Neoplasms